1
|
Altergot A, Ohlmann C, Nüsken F, Palm J, Hecht M, Dzierma Y. Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery. Strahlenther Onkol 2024; 200:815-826. [PMID: 38977432 PMCID: PMC11343813 DOI: 10.1007/s00066-024-02249-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Accepted: 05/21/2024] [Indexed: 07/10/2024]
Abstract
PURPOSE Automated treatment planning for multiple brain metastases differs from traditional planning approaches. It is therefore helpful to understand which parameters for optimization are available and how they affect the plan quality. This study aims to provide a reference for designing multi-metastases treatment plans and to define quality endpoints for benchmarking the technique from a scientific perspective. METHODS In all, 20 patients with a total of 183 lesions were retrospectively planned according to four optimization scenarios. Plan quality was evaluated using common plan quality parameters such as conformity index, gradient index and dose to normal tissue. Therefore, different scenarios with combinations of optimization parameters were evaluated, while taking into account dependence on the number of treated lesions as well as influence of different beams. RESULTS Different scenarios resulted in minor differences in plan quality. With increasing number of lesions, the number of monitor units increased, so did the dose to healthy tissue and the number of interlesional dose bridging in adjacent metastases. Highly modulated cases resulted in 4-10% higher V10% compared to less complex cases, while monitor units did not increase. Changing the energy to a flattening filter free (FFF) beam resulted in lower local V12Gy (whole brain-PTV) and even though the number of monitor units increased by 13-15%, on average 46% shorter treatment times were achieved. CONCLUSION Although no clinically relevant differences in parameters where found, we identified some variation in the dose distributions of the different scenarios. Less complex scenarios generated visually more dose overlap; therefore, a more complex scenario may be preferred although differences in the quality metrics appear minor.
Collapse
Affiliation(s)
- Angelika Altergot
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Kirrberger Straße, Homburg/Saar, Germany.
| | - Carsten Ohlmann
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Kirrberger Straße, Homburg/Saar, Germany
| | - Frank Nüsken
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Kirrberger Straße, Homburg/Saar, Germany
| | - Jan Palm
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Kirrberger Straße, Homburg/Saar, Germany
| | - Markus Hecht
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Kirrberger Straße, Homburg/Saar, Germany
| | - Yvonne Dzierma
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Kirrberger Straße, Homburg/Saar, Germany
| |
Collapse
|
2
|
Oshiro Y, Kato Y, Mizumoto M, Sakurai H. The Impact of Multileaf Collimator Size on Single Isocenter Dynamic Conformal Arcs-Based Radiosurgery for Brain Metastases. Cureus 2024; 16:e58816. [PMID: 38784358 PMCID: PMC11113089 DOI: 10.7759/cureus.58816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2024] [Indexed: 05/25/2024] Open
Abstract
PURPOSE To compare the plan quality of stereotactic radiosurgery (SRS) between 2.5-mm and 5-mm multileaf collimator (MLC) and investigate the factors' influence on the differences by MLC size. METHODS Seventy-six treatment plans including 145 targets calculated with a single isocenter multiple noncoplanar dynamic conformal arc (DCA) technique using automatic multiple brain metastases (MBM) treatment planning system. Conformity index (CI), gradient index (GI), lesion underdosage volume factor (LUF), healthy tissue overdose volume factor (HTOF), geometric conformity index (g), and mean dose to normal organs were compared between 2.5-mm and 5-mm MLC. Then the factors that influenced the differences of these parameters were investigated. The impact of target size was also investigated for CI and GI values of individual targets (n=145), and differences between 2.5-mm and 5-mm MLC were analyzed. RESULTS All parameters except for LUF were significantly better in plans with 2.5 mm MLC. Target size was a significant factor for difference in HTOF, and distance between targets was a significant factor for difference in brain dose and GI. Among 145 metastases, the average inverse CI was 1.35 and 1.47 with 2.5-mm and 5-mm MLC, respectively (p<0.001). The average GI was 3.21 and 3.53, respectively (p<0.001). For individual targets, target size was a significant factor in CI and GI both with 2.5-mm and 5-mm MLC (p-value: <0.001, each). CI and GI were significantly better with 2.5-mm than 5-mm MLC. CI was almost >0.67 except for ≤5mm targets with 5-mm MLC. Also, GI was almost smaller than 3.0 for >10 mm targets both with 2.5-mm and 5-mm MLC. CONCLUSIONS MBM with 5-mm MLC was almost fine. However, it may be better to use a conservative margin for larger metastases. It may also be better to avoid SRS with 5-mm MLC for patients with ≤5 mm target size.
Collapse
Affiliation(s)
- Yoshiko Oshiro
- Radiation Oncology, Tsukuba Medical Center Hospital, Tsukuba, JPN
| | - Yuichi Kato
- Radiation Oncology, Tsukuba Medical Center Hospital, Tsukuba, JPN
| | - Masashi Mizumoto
- Radiation Oncology, University of Tsukuba Hospital, Tsukuba, JPN
| | - Hideyuki Sakurai
- Radiation Oncology, University of Tsukuba Hospital, Tsukuba, JPN
| |
Collapse
|
3
|
Priyadarsini V H, R M, Arunainambiraj N. Single-Isocenter Multiple-Target SRS Planning of Five to Ten Brain Metastases Using 5 mm Multileaf Collimator: Relationship between Prescription Dose, Number and Volume of Targets. Asian Pac J Cancer Prev 2023; 24:2455-2463. [PMID: 37505780 PMCID: PMC10676470 DOI: 10.31557/apjcp.2023.24.7.2455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2023] [Accepted: 07/02/2023] [Indexed: 07/29/2023] Open
Abstract
OBJECTIVE To propose an expression relating the number and volume of targets with the prescription dose in determining normal brain volume receiving 12 Gy dose (V12) for five to ten brain metastases treated in linear accelerator-based stereotactic radiosurgery (SRS) planning. To determine the volume of tumor that can be treated within the brain tolerance dose, for different SRS prescription doses. METHODS Single-isocenter multiple-target (SIMT) SRS plans were devised for spherical targets that are modeled to simulate 47 tumor scenarios with varying tumor sizes and locations within the brain. Volumetric modulated arc therapy (VMAT) plans were devised using a 5-mm-leaf-width multi-leaf collimator (MLC) with high conformity and dose gradient in the Eclipse treatment planning system for the 21 Gy prescription dose with a 6FFF photon beam. The prescription dose was rescaled to 20 Gy, 18 Gy, 15 Gy and 12Gy to determine the brain V12 volume for a total of 235 SRS plans. RESULTS Linear correlation was observed between the number, volume and prescription dose of the tumor. The expression relating these parameters was constructed to predict the normal brain V12 volume. The maximum tumor volume that can be treated using SIMT SRS with a 5-mm MLC for 5 to 10 number of targets and for a prescription dose of 21 Gy, 20 Gy, 18 Gy and 15 Gy is determined. CONCLUSION Using the expression obtained, V12 volume can be calculated using the number of tumors and the total volume of tumors from the pre-planning MRI data. The prescription dose and the SRS fractionation size can be determined before radiotherapy treatment planning.
Collapse
Affiliation(s)
- Hemalatha Priyadarsini V
- Tamil Nadu Medical Services Corporation Ltd, 417, Pantheon Road, Egmore, Chennai, Tamil Nadu, 600008, India.
- Department of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
- Department of Radiation Oncology, Government Royapettah Hospital, 1, West Cott Road, Royapettah, Chennai, Tamil Nadu, 600014, India.
| | - Murali R
- Department of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
| | - Narayanasamy Arunainambiraj
- Department of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
| |
Collapse
|
4
|
Ohtakara K, Suzuki K. Modified Dynamic Conformal Arcs With Forward Planning for Radiosurgery of Small Brain Metastasis: Each Double Arc and Different To-and-Fro Leaf Margins to Optimize Dose Gradient Inside and Outside the Gross Tumor Boundary. Cureus 2023; 15:e34831. [PMID: 36919061 PMCID: PMC10008411 DOI: 10.7759/cureus.34831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/09/2023] [Indexed: 02/12/2023] Open
Abstract
Dynamic conformal arcs (DCA) are a widely used technique for stereotactic radiosurgery (SRS) of brain metastases (BM) using a micro-multileaf collimator (mMLC), while the planning design and method considerably vary among institutions. In the usual forward planning of DCA, the steepness of the dose gradient outside and inside the gross tumor volume (GTV) boundary is simply defined by the leaf margin (LM) setting to the target volume edge. The dose fall-off outside the small GTV tends to be excessively precipitous, especially with an MLC of 2.5-mm leaf width, which is predisposed to the insufficient coverage of microscopic brain invasion and other inherent inaccuracies. Meanwhile, insufficient dose increase inside the GTV boundary, i.e., less inhomogeneous GTV dose, likely leads to inferior and less sustainable tumor response. The more inhomogeneous GTV dose is prone to the steeper dose gradient outside the GTV and vice versa. Herein, we describe an alternative simply modified DCA (mDCA) planning that was uniquely devised to optimize the dose gradient outside and inside the GTV boundary for further enhancing and consolidating local control of small BM. For a succinct exemplification, a 10-mm spherical target was assumed as a GTV for DCA planning using a 2.5-mm mMLC. The benchmark plan was generated by adding a 0-mm LM to the GTV edge by assigning a single fraction of 30 Gy to the isocenter, in which the GTV coverage by 24 Gy with 80% isodose surface (IDS) was 96%, i.e., D96%, while the coverage of GTV + isotropic 2 mm volume by 18 Gy with 60% IDS was 70%, with the D98% being 12 Gy with 40% IDS, viz., too steep dose fall-off outside the GTV boundary. Alternatively, the increase of LM with or without decreasing the isocenter dose enables the increase of the GTV + 2 mm coverage by 18 Gy while resulting in an inadequate GTV dose with either a less inhomogeneous dose or an excessive marginal dose. Meanwhile, in the newly devised mDCA planning, every single arc was converted to a double to-and-fro arc with different LM settings under the same spatial arrangement, which enabled GTV + 2 mm volume coverage with 18 Gy while preserving the GTV marginal dose and inhomogeneity similar to those for the benchmark plan. Additionally, the different collimator angle (CA) setting for the to-and-fro arcs led to further trimming of the dose conformity. The limitations of general forward planning with only adjusting the LM for every single arc were demonstrated, which can be a contributing factor for local tumor progression of small BM. Alternatively, the mDCA with each double to-and-fro arc and different LM and CA settings enables optimization of the dose gradient both outside and inside the GTV boundary according to the planners' intent, e.g., moderate dose spillage margin outside the GTV and steep dose increase inside the GTV boundary.
Collapse
Affiliation(s)
- Kazuhiro Ohtakara
- Department of Radiation Oncology, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi, JPN.,Department of Radiology, Aichi Medical University, Nagakute, JPN
| | - Kojiro Suzuki
- Department of Radiology, Aichi Medical University, Nagakute, JPN
| |
Collapse
|
5
|
Desai DD, Cordrey IL, Johnson EL. Efficient optimization of R50% when planning multiple cranial metastases simultaneously in single isocenter SRS/SRT. J Appl Clin Med Phys 2021; 22:71-82. [PMID: 33960619 PMCID: PMC8200517 DOI: 10.1002/acm2.13254] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Revised: 03/26/2021] [Accepted: 04/03/2021] [Indexed: 12/26/2022] Open
Abstract
Simultaneous optimization of multiple Planning Target Volumes (PTVs) of varying size and location in the cranium is a non-trivial task. The rate of dose falloff around PTV structures is variable and depends on PTV characteristics such as the volume. The metric R50% is one parameter that can be used to quantify dose falloff achieved in a given treatment plan. An important treatment planning question is how to construct optimization conditions that result in the efficient production of acceptable plan outcomes considering metrics such as R50%. Guidance provided in literature suggests generating multiple shell control structures around each PTV. The constraints applied to these shells can vary significantly depending on PTV volume. Additionally, there is no clear guidance on how to prospectively determine objective constraints for the optimization shells to achieve a specified goal of R50%. Based on physical principles and empirical evidence, we provide clear quantitative guidance on how to translate the desired R50% outcome into appropriately sized optimization structures around PTVs via an equation that depends on a desired goal for R50% and the volume of PTV. Optimization schema are also provided that allow the goal R50% to be approached or achieved for all PTVs individually. We demonstrate the application of the methodology using commercially available treatment planning software and radiotherapy treatment equipment.
Collapse
Affiliation(s)
- Dharmin D Desai
- Department of Radiation Oncology, CHI Memorial Hospital, Chattanooga, TN, USA
| | - Ivan L Cordrey
- Department of Radiation Oncology, CHI Memorial Hospital, Chattanooga, TN, USA
| | - E L Johnson
- Department of Radiation Medicine, University of Kentucky Chandler Medical Center, Lexington, KY, USA
| |
Collapse
|
6
|
Knill C, Sandhu R, Halford R, Snyder M, Seymour Z. Commissioning cranial single-isocenter multi-target radiosurgery for the Versa HD. J Appl Clin Med Phys 2021; 22:108-114. [PMID: 33756044 PMCID: PMC8035552 DOI: 10.1002/acm2.13223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Revised: 01/29/2021] [Accepted: 02/16/2021] [Indexed: 11/12/2022] Open
Abstract
PURPOSE Brainlab's Elements Multiple Brain Mets SRS (MBMS) is a dedicated treatment planning system for single-isocenter multi-target (SIMT) cranial stereotactic radiosurgery (SRS) treatments. The purpose of this study is to present the commissioning experience of MBMS on an Elekta Versa HD. METHODS MBMS was commissioned for 6 X, 6 FFF, and 10 FFF. Beam data collected included: output factors, percent depth doses (PDDs), diagonal profiles, collimator transmission, and penumbra. Beam data were processed by Brainlab and resulting parameters were entered into the planning system to generate the beam model. Beam model accuracy was verified for simple fields. MBMS plans were created on previously treated cranial SRS patient data sets. Plans were evaluated using Paddick inverse conformity (ICI), gradient indices (GI), and cumulative volume of brain receiving 12 Gy. Dosimetric accuracy of the MBMS plans was verified using microDiamond, Gafchromic film, and SRS Mapcheck measurements of absolute dose and dose profiles for individual targets. Finally, an end-to-end (E2E) test was performed with a MR-CT compatible phantom to validate the accuracy of the simulation-to-delivery process. RESULTS For square fields, calculated scatter factors were within 1.0% of measured, PDDs were within 0.5% past dmax, and diagonal profiles were within 0.5% for clinically relevant off-axis distances (<10 cm). MBMS produced plans with ICIs < 1.5 and GIs < 5.0 for targets > 10 mm. Average point doses of the MBMS plans, measured by microDiamond, were within 0.31% of calculated (max 2.84%). Average per-field planar pass rates were 98.0% (95.5% minimum) using a 2%/1 mm/10% threshold relative gamma analysis. E2E point dose measurements were within 1.5% of calculated and Gafchromic film pass rates were 99.6% using a 5%/1 mm/10% threshold gamma analysis. CONCLUSION The experience presented can be used to aid the commissioning of the Versa HD in the Brainlab MBMS treatment planning system, to produce safe and accurate SIMT cranial SRS treatments.
Collapse
Affiliation(s)
- Cory Knill
- Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, 48073, USA
| | - Raminder Sandhu
- Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, 48073, USA
| | - Robert Halford
- Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, 48073, USA
| | - Michael Snyder
- Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, 48073, USA
| | - Zachary Seymour
- Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, 48073, USA
| |
Collapse
|
7
|
Chea M, Fezzani K, Jacob J, Cuttat M, Croisé M, Simon JM, Feuvret L, Valery CA, Maingon P, Benadjaoud MA, Jenny C. Dosimetric study between a single isocenter dynamic conformal arc therapy technique and Gamma Knife radiosurgery for multiple brain metastases treatment: impact of target volume geometrical characteristics. Radiat Oncol 2021; 16:45. [PMID: 33639959 PMCID: PMC7912819 DOI: 10.1186/s13014-021-01766-w] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Accepted: 02/11/2021] [Indexed: 12/14/2022] Open
Abstract
Purpose To compare linac-based mono-isocentric radiosurgery with Brainlab Elements Multiple Brain Mets (MBM) SRS and the Gamma Knife using a specific statistical method and to analyze the dosimetric impact of the target volume geometric characteristics. A dose fall-off analysis allowed to evaluate the Gradient Index relevancy for the dose spillage characterization. Material and methods Treatments were planned on twenty patients with three to nine brain metastases with MBM 2.0 and GammaPlan 11.0. Ninety-five metastases ranging from 0.02 to 9.61 cc were included. Paddick Index (PI), Gradient Index (GI), dose fall-off, volume of healthy brain receiving more than 12 Gy (V12Gy) and DVH were used for the plan comparison according to target volume, major axis diameter and Sphericity Index (SI). The multivariate regression approach allowed to analyze the impact of each geometric characteristic keeping all the others unchanged. A parallel study was led to evaluate the impact of the isodose line (IDL) prescription on the MBM plan quality. Results For mono-isocentric linac-based radiosurgery, the IDL around 70–75% was the best compromise found. For both techniques, the GI and the dose fall-off decreased with the target volume. In comparison, PI was slightly improved with MBM for targets < 1 cc or SI > 0.78. GI was improved with GP for targets < 2.5 cc. The V12Gy was higher with MBM for lesions > 0.4 cc or SI < 0.84 and exceeded 10 cc for targets > 5 cc against 6.5 cc with GP. The presence of OAR close to the PTV had no impact on the dose fall off values. The dose fall-off was higher for volumes < 3.8 cc with GP which had the sharpest dose fall-off in the infero-superior direction up to 30%/mm. The mean beam-on time was 94 min with GP against 13 min with MBM. Conclusions The dose fall-off and the V12Gy were more relevant indicators than the GI for the low dose spillage assessment. Both evaluated techniques have comparable plan qualities with a slightly improved selectivity with MBM for smaller lesions but with a healthy tissues sparing slightly favorable to GP at the expense of a considerably longer irradiation time. However, a higher healthy tissue exposure must be considered for large volumes in MBM plans.
Collapse
Affiliation(s)
- Michel Chea
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France.
| | - Karen Fezzani
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Julian Jacob
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Marguerite Cuttat
- Neurosurgery Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, Paris, France
| | - Mathilde Croisé
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Jean-Marc Simon
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Loïc Feuvret
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Charles-Ambroise Valery
- Neurosurgery Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, Paris, France
| | - Philippe Maingon
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Mohamed-Amine Benadjaoud
- PSE-SANTE/SERAMED, Radiation Protection and Nuclear Safety Institute, Fontenay aux Roses, France
| | - Catherine Jenny
- Radiation Oncology Department, Pitié-Salpêtrière Hospital, AP-HP Sorbonne University, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| |
Collapse
|